-
Product Insights
Ebolavirus Infections (Ebola Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Ebolavirus Infections pipeline market report provides a comprehensive overview on the therapeutics under development for Ebolavirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ebolavirus Infections and features dormant...
-
Product Insights
Influenza A Virus, H1N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Influenza A Virus, H1N1 Subtype Infections pipeline market report provides a comprehensive overview on the therapeutics under development for Influenza A Virus, H1N1 Subtype Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in...
-
Product Insights
Toxoplasmosis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Toxoplasmosis Global Clinical Trials Review, H2, 2018" provides an overview of Toxoplasmosis clinical trials scenario. This report provides top line data relating to the clinical trials on Toxoplasmosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...